Celosome

Celosome dermal fillers utilize advanced 8-stage purification (BDDE <0.2ppm) and HENM cross-linking technology, containing 24 mg/ml stabilized hyaluronic acid with 0.3% lidocaine. Clinically proven to correct moderate-severe wrinkles and enhance facial contours through mid-dermal placement, delivering immediate volumizing effects and sustained collagen stimulation for 12-24 months with 92% patient satisfaction in trials.

Celosome Dermal Fillers​​ Stabilized HA-based (24mg/ml) injectables for precise facial contouring (chin/jawline) and volumization (cheeks/nose bridge) using HENM cross-linking technology. Contains 0.3% lidocaine (68% pain reduction) with <0.2ppm BDDE residues and <0.05 EU/ml endotoxins. CE/ISO-certified, clinically proven 12-24 month longevity and 92% patient satisfaction. Minimizes edema and bruising risks.

Celosome HA Fillers​​ Medical-grade hyaluronic acid dermal fillers (24 mg/mL) with 0.3% lidocaine for mid-to-deep wrinkle correction (nasolabial folds, marionette lines) and liquid facelifts. Features patented HENM cross-linking technology, ensuring <0.1 ppm BDDE residues and 99.9% purity. Clinically proven: 40% lower edema risk, 92% patient satisfaction at 6 months, 9-18 month longevity. Non-animal HA with rapid recovery (78% resume activities in 24h).

​​Celosome HA Fillers​​ (24mg/ml with 0.3% lidocaine) utilize 8-phase purification (≥99.2% purity, BDDE <0.5ppm) and HENM cross-linking technology for precise facial rejuvenation. Ideal for fine wrinkles (forehead/glabellar/perioral) and lip augmentation, it ensures smooth injection (27G needle), 40% pain reduction, and 6-9 month longevity with 92% patient satisfaction in clinical trials.